THE ROLE OF BIOMATERIALS IN MODULATING CARDIAC REMODELING AND PROMOTING MYOCARDIAL REPAIR

Authors

  • Irgasheva D.G. Department of Normal Physiology Assistant Andijan state medical institute. Author

Keywords:

myocardial infarction; biomaterials; cardiac repair; hydrogels; cardiomyocytes; inflammation; angiogenesis; ventricular remodeling.

Abstract

 The healthy heart comprises many different cell types that work together to preserve optimal function. However, in a diseased heart the function of one or more cell types is compromised which can lead to many adverse events, one of which is myocardial infarction (MI). Immediately after MI, the cardiac environment is characterized by excessive cardiomyocyte death and inflammatory signals leading to the recruitment of macrophages to clear the debris. Proliferating fibroblasts then invade, and a collagenous scar is formed to prevent rupture. Better functional restoration of the heart is not achieved due to the limited regenerative capacity of cardiac tissue. To address this, biomaterial therapy is being investigated as an approach to improve regeneration in the infarcted heart, as they can possess the potential to control cell function in the infarct environment and limit the adverse compensatory changes that occur post-MI.

Objective. This review is to critically evaluate the current evidence on the effects of biomaterials on different cell types involved in cardiac repair and regeneration following myocardial infarction. Particular attention is given to the interactions of biomaterials with cardiomyocytes, fibroblasts, endothelial cells, macrophages, cardiac progenitor cells, and mesenchymal stromal cells, as well as their effects on inflammation, angiogenesis, fibrosis, extracellular matrix remodeling, and cellular survival.

Materials and Methods. A structured literature review was conducted to identify and evaluate studies investigating the effects of biomaterials on cellular processes involved in cardiac repair and regeneration following myocardial infarction. The review was designed in accordance with the principles of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines.

Results and Discussion. The reviewed literature demonstrates a substantial expansion of biomaterial-based approaches for myocardial repair following myocardial infarction (MI). The biological effects of biomaterials were found to depend strongly on their composition, mechanical properties, degradation characteristics, architecture, surface chemistry, and the presence of incorporated biological signals.

Conclusion. Biomaterials can support cardiomyocyte survival, promote endothelial cell-mediated angiogenesis, regulate macrophage-driven inflammation, modulate fibroblast activation and extracellular matrix remodeling, and improve the retention and regenerative activity of stem and mesenchymal stromal cells. These coordinated cellular effects may contribute to reduced adverse ventricular remodeling and improved structural and functional recovery of the injured myocardium

References

1.Lister Z, Rayner KJ, Suuronen EJ. How biomaterials can influence various cell types in the repair and regeneration of the heart after myocardial infarction. Front Bioeng Biotechnol. 2016;4:62. doi:10.3389/fbioe.2016.00062.

2.Ahmadi A, McNeill B, Vulesevic B, Kordos M, Mesana L, Thorn S, et al. The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium. Biomaterials. 2014;35:4749–4758.

3.Ahmadi A, Vulesevic B, Blackburn NJR, Ruel JJM, Suuronen EJ. A collagen-chitosan injectable hydrogel improves cardiac remodeling in a mouse model of myocardial infarction. J Biomater Tissue Eng. 2014;4:886–894. doi:10.1166/jbt.2014.1264.

4.Awada HK, Hwang MP, Wang Y. Biomaterials for comprehensive cardiac repair and regeneration after myocardial infarction: aspects to consider and proteins to deliver. Biomaterials. 2016;82:94–112. doi:10.1016/j.biomaterials.2015.12.025.

5.Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A. 2008;14:1835–1842. doi:10.1089/ten.tea.2007.0264.

6.Baei P, Jalili-Firoozinezhad S, Rajabi-Zeleti S, Tafazzoli-Shadpour M, Baharvand H, Aghdami N. Electrically conductive gold nanoparticle-chitosan thermosensitive hydrogels for cardiac tissue engineering. Mater Sci Eng C. 2016;63:131–141.

7.Bayomy AF, Bauer M, Qiu Y, Liao R. Regeneration in heart disease—is extracellular matrix the key? Life Sci. 2012;91:823–827. doi:10.1016/j.lfs.2012.08.034.

8.Blackburn NJR, Sofrenovic T, Kuraitis D, Ahmadi A, McNeill B, Deng C, et al. Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction. Biomaterials. 2015;39:182–192. doi:10.1016/j.biomaterials.2014.11.004.

Downloads

Published

2026-11-07